You are here

asthma

GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month

Fierce Pharma

Thu, 03/21/24 - 06:37 pm

Boehringer Ingelheim

RAPT Therapeutics Shares Plunge Premarket on FDA Study Hold

Morningstar

Tue, 02/20/24 - 11:17 am

RAPT Therapeutics

clinical trials

atopic dermatits

Discontinued GSK asthma drug stirs frustrations

Beckers Hospital Review

Wed, 02/14/24 - 06:36 pm

GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline

BioSpace

Tue, 01/9/24 - 09:50 am

Connect Biopharma plots phase 3 regulatory path after asthma asset hits mid-stage trial goals

Fierce Biotech

Tue, 12/12/23 - 11:21 am

Connect Biopharma

clinical trials

Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med

Fierce Biotech

Tue, 10/24/23 - 09:48 am

Apogee Files for IPO with Promising Preclinical Immuno Asset

BioSpace

Sun, 06/25/23 - 09:37 pm

Paragon Therapeutics

atopic dermatitis

Pieris stock deflates as AstraZeneca stops trials of asthma drug in response to toxicology signal

Fierce Biotech

Wed, 06/21/23 - 10:54 am

clinical trials

AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE

Fierce Pharma

Wed, 03/29/23 - 09:58 am

Dupixent kicks off 2023 as top pharma brand for ad impressions

Medical Devices and Diagnostics Industry

Mon, 02/6/23 - 06:13 pm

pharma advertising

AstraZeneca and Avillion win approval for new asthma rescue treatment in adults

Endpoints

Wed, 01/11/23 - 10:53 am

Could AstraZeneca's Asthma Drug Candidate Generate Billions?

Motley Fool

Tue, 12/20/22 - 10:44 am

Yes, no, maybe: FDA panel delivers mixed verdict on AstraZeneca's asthma rescue medication

Fierce Biotech

Wed, 11/9/22 - 10:43 am

Sanofi, Regeneron team with Broadway actor for digital severe asthma program

Medical Marketing and Media

Wed, 10/19/22 - 10:54 pm

pharma marketing

AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’

Endpoints

Wed, 10/5/22 - 10:35 am

pharma marketing

DTC advertising

eosinophilic asthma

Sanofi’s asthma therapy shows consistent safety profile in Phase III trial

Clinical Trials Arena

Tue, 09/6/22 - 05:06 pm

clinical trials

Moving Away from Asthma and COPD, Novartis Hones in on 20 Approvals by 2026

BioSpace

Thu, 07/21/22 - 10:24 am

Transpire Bio signs with Recipharm for inhaled medicine development

European Pharmaceutical Review

Tue, 07/19/22 - 10:38 am

drug development

Novartis looking for new homes for midphase asthma, eye disease and NASH assets after pipeline review

Fierce Biotech

Tue, 07/19/22 - 10:36 am

Retinitis pigmentosa

Areteia gets $350M to turn failed ALS drug into a therapy for severe asthma

MedCity News

Tue, 07/12/22 - 11:29 pm

Areteia Therapeutics

eosinophilic asthma

Pages